|
1
|
Campo-Paysaa F, Marlétaz F, Laudet V and
Schubert M: Retinoic acid signaling in development: tissue-specific
functions and evolutionary origins. Genesis. 46:640–656. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mark M, Ghyselinck NB and Chambon P:
Function of retinoic acid receptors during embryonic development.
Nucl Recept Signal. 7:e0022009.PubMed/NCBI
|
|
3
|
McKenna NJ and O’Malley BW: Combinatorial
control of gene expression by nuclear receptors and coregulators.
Cell. 108:465–474. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li JJ, Dong Z, Dawson MI and Colburn NH:
Inhibition of tumor promoter-induced transformation by retinoids
that transrepress AP-1 without transactivating retinoic acid
response element. Cancer Res. 56:483–489. 1996.PubMed/NCBI
|
|
5
|
Liu S, Wu Q, Chen ZM and Su WJ: The effect
pathway of retinoic acid through regulation of retinoic acid
receptor alpha in gastric cancer cells. World J Gastroenterol.
7:662–666. 2001.PubMed/NCBI
|
|
6
|
Sundqvist A, Zieba A, Vasilaki E, Herrera
Hidalgo C, Söderberg O, Koinuma D, Miyazono K, Heldin CH, Landegren
U, Ten Dijke P and van Dam H: Specific interactions between Smad
proteins and AP-1 components determine TGFβ-induced breast cancer
cell invasion. Oncogene. 32:3606–3615. 2013.PubMed/NCBI
|
|
7
|
McKenna NJ: EMBO Retinoids 2011:
Mechanisms, biology and pathology of signaling by retinoic acid and
retinoic acid receptors. Nucl Recept Signal. 10:e0032012.PubMed/NCBI
|
|
8
|
Kilewer SA, Umesono K, Noonan DJ, Heyman
RA and Evans RM: Covergence of 9-cis retinoic acid and peroxisome
proliferator signaling pathways through heterodimer formation of
their receptors. Nature. 358:771–774. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dierov J, Sawaya BE, Prosniak M and
Gartenhaus RB: Retinoic acid modulates a bimodal effect on cell
cycle progression in human adult T-cell leukemia cells. Clin Cancer
Res. 5:2540–2547. 1999.PubMed/NCBI
|
|
10
|
Tillmanns TD, Kamelle SA, Guruswamy S,
Gould NS, Rutledge TL and Benbrook DM: Sensitization of cervical
cancer cell lines to low-dose radiation by retinoic acid does not
require functional p53. Gynecol Oncol. 97:142–150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lehmann S, Ravn A, Carlsson L, Antunovic
P, Deneberg S, Möllgård L, Derolf AR, Stockelberg D, Tidefelt U,
Wahlin A, Wennström L, Höglund M and Juliusson G: Continuing high
early death rate in acute promyelocytic leukemia: a
population-based report from the Swedish Adult Acute Leukemia
Registry. Leukemia. 25:1128–1134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pagoni M, Garofalaki M, Panitsas F, Manola
K, Psarra K, Economopoulos P, Vourtsi A, Antoniades M, Gkirkas K,
Tzouvara E, Katis F, Prokopiou C, Tziotziou I, Balta A, Lemissiou
E, Tsirigotis P, Repoussis P and Harhalakis N: Acute promyelocytic
leukemia: an experience on 95 greek patients treated in the
all-trans-retinoic acid era. Mediterr J Hematol Infect Dis.
3:e20110532011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park JH, Qiao B, Panageas KS, Schymura MJ,
Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM and Tallman
MS: Early death rate in acute promyelocytic leukemia remains high
despite all-trans retinoic acid. Blood. 118:1248–1254. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Latagliata R, Petti MC, Fenu S, Mancini M,
Spiriti MA, Breccia M, Brunetti GA, Avvisati G, Lo Coco F and
Mandelli F: Therapy-related myelodysplastic syndrome-acute
myelogenous leukaemia in patients treated for acute promyelocytic
leukaemia: an emerging problem. Blood. 99:822–824. 2002. View Article : Google Scholar
|
|
15
|
Zompi S and Viguie F: Therapy-related
acute myeloid leukaemia and myelodysplasia after successful
treatment of acute promyelocytic leukaemia. Leuk Lymphoma.
43:275–280. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Simoni D, Rondanin R, Baruchello R,
Roberti M, Rossi M, Grimaudo S, D’Alessandro N, Invidiata FP and
Tolomeo M: Retinoic acid and analogs as potent inducers of
differentiation and apoptosis. New promising chemopreventive and
chemotherapeutic agents in oncology. Pure Appl Chem. 73:1437–1444.
2001. View Article : Google Scholar
|
|
17
|
Adamson PC: All-trans-retinoic acid
pharmacology and its impact on the treatment of acute promyelocytic
leukemia. Oncologist. 1:305–314. 1996.PubMed/NCBI
|
|
18
|
Allenby G, Bocquel MT, Saunders M, Kazmer
S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P
and Levin AA: Retinoic acid receptors and retinoid X receptors
interactions with endogenous retinoic acids. Proc Natl Acad Sci
USA. 90:30–34. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang J, Yao J, Shi J, Xiao Q, Zhou J and
Chen F: Synthesis, characterization, drug-loading capacity and
safety of novel pH-independent amphiphilic amino acid copolymer
micelles. Pharmazie. 67:756–764. 2012.PubMed/NCBI
|
|
20
|
Ahn HK, Jang J, Lee J, Se Hoon P, Park JO,
Park YS, Lim HY, Kim KM and Kang WK: P21-activated kinase 4
overexpression in metastatic gastric cancer patients. Transl Oncol.
4:345–349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li CJ, Chu CY, Huang LH, Wang MH, Sheu LF,
Yeh JI and Hsu HY: Synergistic anticancer activity of triptolide
combined with cisplatin enhances apoptosis in gastric cancer in
vitro and in vivo. Cancer Lett. 319:203–213. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kizaki M, Dawson MI, Heyman R, Elster E,
Morosetti R, Pakkala S, Chen DL, Ueno H, Chao W, Morikawa M, Ikeda
Y, Heber D, Pfahl M and Koeffler HP: Effects of novel retinoid X
receptor-selective ligands on myeloid leukemia differentiation and
proliferation in vitro. Blood. 87:1977–1984. 1996.PubMed/NCBI
|
|
23
|
Zang C, Wächter M, Liu H, Posch MG, Fenner
MH, Stadelmann C, von Deimling A, Possinger K, Black KL, Koeffler
HP and Elstner E: Ligands for PPARgamma and RAR cause induction of
growth inhibition and apoptosis in human glioblastomas. J
Neurooncol. 65:107–118. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang N, Ge JF, Pan CX, Peng XQ, Chen HH,
Wang XQ, Tang J, Hu W and Chen FH: Anti-tumor effect of
4-Amino-2-Trifluoromethyl-Phenyl Retinate on human breast cancer
MCF-7 cells via up-regulation of retinoid receptor-induced gene-1.
Biomed Pharmacother. 67:687–692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu Q, Chen YQ, Chen ZM, Chen F and Su WJ:
Effects of retinoic acid on metastasis and its related proteins in
gastric cancer cells in vivo and in vitro. Acta Pharmacol Sin.
23:835–841. 2002.PubMed/NCBI
|
|
26
|
Zhang JP, Chen XY and Li JS: Effects of
all-trans-retinoic on human gastric cancer cells BGC-823. J Dig
Dis. 8:29–34. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Agadir A, Shealy YF, Hill DL and Zhang X:
Retinyl methyl ether down-regulates activator protein 1
transcriptional activation in breast cancer cells. Cancer Res.
57:3444–3450. 1997.PubMed/NCBI
|
|
28
|
Wan H, Dawson MI, Hong WK and Lotan R:
Enhancement of Calu-1 human lung carcinoma cell growth in
serum-free medium by retinoids: dependence on AP-1 activation, but
not on retinoid response element activation. Oncogene.
15:2109–2118. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu Q, Chen ZM and Su WJ: Anticancer effect
of retinoic acid via AP-1 activity repression is mediated by
retinoic acid receptor alpha and beta in gastric cancer cells. Int
J Biochem Cell Biol. 34:1102–1114. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cory S and Adams JM: Killing cancer cells
by flipping the Bcl-2/Bax switch. Cancer Cell. 8:5–6. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reed JC: Proapoptotic multidomain
Bcl-2/Bax-family proteins: mechanisms, physiological roles, and
therapeutic opportunities. Cell Death Differen. 13:1378–1386. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tacar O, Sriamornsak P and Dass CR:
Doxorubicin: an update on anticancer molecular action, toxicity and
novel drug delivery systems. J Pharm Pharmacol. 65:157–170. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Albano F, Arcucci A, Granato G, Romano S,
Montagnani S, De Vendittis E and Ruocco MR: Markers of
mitochondrial dysfunction during the diclofenac-induced apoptosis
in melanoma cell lines. Biochimie. 95:934–945. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mazumder S, Plesca D and Almasan A: A
jekyll and hyde role of cyclin E in the genotoxic stress response:
switching from cell cycle control to apoptosis regulation. Cell
Cycle. 6:1437–1442. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
López-Carballo G, Moreno L, Masiá S, Pérez
P and Barettino D: Activation of the phosphatidylinositol
3-kinase/Akt signaling pathway by retinoic acid is required for
neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol
Chem. 277:25297–25304. 2002.
|
